Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis

Abstract

Monthly methylprednisolone pulse treatment was safe, but had no effect on the primary outcome. However, improvements in secondary clinical and MRI outcome measures suggest that this treatment regimen may have a beneficial effect in progressive MS.